181
Views
0
CrossRef citations to date
0
Altmetric
Research Article

West Nile virus meningoencephalitis and cytokines analysis: review and case report

ORCID Icon, , , , & ORCID Icon
Article: 2358991 | Received 19 Feb 2024, Accepted 18 May 2024, Published online: 03 Jun 2024

References

  • Factsheet about West Nile virus infection. https://www.ecdc.europa.eu/en/west-nile-fever/facts.
  • Mrzljak A, Dinjar-Kujundzic P, Santini M, et al. West Nile virus: an emerging threat in transplant population. Vector Borne Zoonotic Dis. 2020;20(8):613–618. doi: 10.1089/vbz.2019.2608.
  • Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310(3):308–315. doi: 10.1001/jama.2013.8042.
  • Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290(4):511–515. doi: 10.1001/jama.290.4.511.
  • Christova I, Panayotova E, Trifonova I, et al. Unexpectedly high number of West Nile neuroinvasive diseases in Bulgaria in 2018. Probl Inf Parasit Dis. 2018;46(2):16–19.
  • Joubert L, Oudar J, Hannoun C, et al. Epidemiology of the West Nile virus: study of a focus in Camargue. IV. Meningo-encephalomyelitis of the horse. Ann Inst Pasteur (Paris). 1970;118(2):239–247.
  • European Center for Disease Prevention and Control. West Nile fever transmission season. Stockholm: ECDC; 2018. Available from: https://www.ecdc.europa.eu/en/news-events/epidemiological-update-west-nile-virus-transmission-season-europe-2018
  • Effects of climate change on vector-borne diseases: an updated focus on West Nile virus in humans. Emerg Top Life Sci. 2019;3(2):143–152.
  • Soto RA, Hughes ML, Staples JE, et al. West Nile virus and other domestic nationally notifiable arboviral Diseases - United States, 2020. MMWR Morb Mortal Wkly Rep. 2022;71(18):628–632. doi: 10.15585/mmwr.mm7118a3.
  • Fall G, Di Paola N, Faye M, et al. Biological and phylogenetic characteristics of west african lineages of West Nile virus. PLoS Negl Trop Dis. 2017;11(11):e0006078. doi: 10.1371/journal.pntd.0006078.
  • West Nile virus. Transmission. Centers for Disease Control and Prevention. Available from: www.cdc.gov/westnile/index.html.
  • Centers for Disease Control and Prevention (CDC). Intrauterine West Nile virus infection -New York, 2002. MMWRMorb Mortal Wkly Rep. 2002;51(50):1135–1136.
  • Coroian M, Petrić M, Pistol A, et al. Human West Nile Meningo-Encephalitis in a highly endemic country: a complex epidemiological analysis on biotic and abiotic risk factors. Int J Environ Res Public Health. 2020;17(21):8250. doi: 10.3390/ijerph17218250.
  • Monastiri A, Mechri B, Vázquez-González A, et al. A four-year survey (2011-2014) of West Nile virus infection in humans, mosquitoes and birds, including the 2012 meningoencephalitis outbreak in Tunisia. Emerg Microbes Infect. 2018;7(1):28. doi: 10.1038/s41426-018-0028-y.
  • Benzarti E, Murray KO, Ronca SE. Interleukins, chemokines, and tumor necrosis factor superfamily ligands in the pathogenesis of West Nile virus infection. Viruses. 2023;15(3):806. doi: 10.3390/v15030806.
  • Donadieu E, Bahuon C, Lowenski S, et al. Differential virulence and pathogenesis of West Nile viruses. Viruses. 2013;5(11):2856–2880. doi: 10.3390/v5112856.
  • Zidovec-Lepej S, Vilibic-Cavlek T, Barbic L, et al. Antiviral cytokine response in neuroinvasive and non-neuroinvasive West Nile virus infection. Viruses. 2021;13(2):342. doi: 10.3390/v13020342.
  • Stonedahl S, Clarke P, Tyler KL. The role of microglia during West Nile virus infection of the central nervous system. Vaccines (Basel). 2020;8(3):485. doi: 10.3390/vaccines8030485.
  • Constant O, Barthelemy J, Nagy A, et al. West Nile virus neuroinfection in humans: peripheral biomarkers of neuroinflammation and neuronal damage. Viruses. 2022;14(4):756. doi: 10.3390/v14040756.
  • Hoffman KW, Sachs D, Bardina SV, et al. Differences in early cytokine production are associated with the development of a greater number of symptoms following West Nile virus infection. J Infect Dis. 2016;214(4):634–643. doi: 10.1093/infdis/jiw179.
  • Garcia MN, Hause AM, Walker CM, et al. Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines. Viral Immunol. 2014;27(7):327–333. doi: 10.1089/vim.2014.0035.
  • Huang B, West N, Vider J, et al. Inflammatory responses to a pathogenic West Nile virus strain. BMC Infect Dis. 2019;19(1):912. doi: 10.1186/s12879-019-4471-8.
  • Santini M, Haberle S, Židovec-Lepej S, et al. Severe West Nile virus neuroinvasive disease: clinical characteristics, short- and long-term outcomes. Pathogens. 2022;11(1):52. doi: 10.3390/pathogens11010052.
  • Koch M, Pozsgai É, Soós V, et al. Identifying risks for severity of neurological symptoms in Hungarian West Nile virus patients. BMC Infect Dis. 2021;21(1):65. doi: 10.1186/s12879-020-05760-7.
  • Bampali M, Konstantinidis K, Kellis EE, et al. West Nile disease symptoms and comorbidities: a systematic review and analysis of cases. Trop Med Infect Dis. 2022;7(9):236. doi: 10.3390/tropicalmed7090236.
  • Pacenti M, Sinigaglia A, Franchin E, et al. Human West Nile virus lineage 2 infection: Epidemiological, clinical, and virological findings. Viruses. 2020;12(4):458. doi: 10.3390/v12040458.
  • Gorchakov R, Gulas-Wroblewski BE, Ronca SE, et al. Optimizing PCR detection of West Nile virus from body fluid specimens to delineate natural history in an infected human cohort. Int J Mol Sci. 2019;20(8):1934. doi: 10.3390/ijms20081934.
  • West Nile virus disease therapeutics. Review of the literature for health care providers. National Center for Emerging and Zoonotic Disease; 2015 https://www.cdc.gov/westnile/resources/pdfs/wnv-therapeutics-summary.pdf.
  • Lim SP, Shi PY. West Nile virus drug discovery. Viruses. 2013;5(12):2977–3006. doi: 10.3390/v5122977.
  • Baymakova M, Trifonova I, Panayotova E, et al. Fatal case of West Nile neuroinvasive disease in Bulgaria. Emerg Infect Dis. 2016;22(12):2203–2204. doi: 10.3201/eid2212.151968.
  • Baymakova M, Christova I, Panayotova E, et al. West Nilevirus infection with neurological disorders: a case report and a brief review of the situationin Bulgaria. Acta Clin Croat. 2019;58(3):546–549. doi: 10.20471/acc.2019.58.03.21.
  • Baymakova M, Popov G, Tsachev I, et al. West Nile fever: the epidemiological situations in Europe, USA and Bulgaria. Gen Med. 2019;21(2):52–58.
  • Christova I. Vector-Borne Infections in Bulgaria.2018. doi: 10.5772/intechopen.81916.
  • Christova I, Panayotova E, Tchakarova S, et al. A nationwide seroprevalence screening for West Nile virus and tick-borne encephalitis virus in the population of Bulgaria. J Med Virol. 2017;89(10):1875–1878. doi: 10.1002/jmv.24855.
  • Christova I, Papa A, Trifonova I, et al. West Nile virus lineage 2 in humans and mosquitoes in Bulgaria, 2018-2019. J Clin Virol. 2020;127:104365. doi: 10.1016/j.jcv.2020.104365.
  • Pishmisheva-Peleva M, Christova I, Kotsev S, et al. West Nile virus fever in Bulgaria – clinical features – analysis of a 2-year period. Gen Med. 2020;22(3):8–15.
  • Abdalla AA, Fanciullo J, Ateeli H. Delayed diagnosis of West Nile meningoencephalitis in a patient receiving rituximab for rheumatoid arthritis. Cureus. 2022;14(10):e30221. doi: 10.7759/cureus.30221.
  • Pem-Novosel I, Vilibic-Cavlek T, Gjenero-Margan I, et al. First outbreak of West Nile virus neuroinvasive disease in humans, Croatia, 2012. Vector Borne Zoonotic Dis. 2014;14(1):82–84. doi: 10.1089/vbz.2012.1295.
  • García San MiguelRodríguez-Alarcón L, Fernández-Martínez B, Sierra Moros MJ, et al. Unprecedented increase of West Nile virus neuroinvasive disease, Spain, summer 2020. Euro Surveill. 2021;26(19):2002010. doi: 10.2807/1560-7917.ES.2021.26.19.2002010.
  • Jani C, Walker A, Al Omari O, et al. Acute transverse myelitis in West Nile virus, a rare neurological presentation. IDCases. 2021;24:e01104. doi: 10.1016/j.idcr.2021.e01104.
  • Santini M, Zupetic I, Viskovic K, et al. Cauda equine arachnoiditis - a rare manifestation of West Nile virus neuroinvasive disease: a case report. World J Clin Cases. 2020;8(17):3797–3803. doi: 10.12998/wjcc.v8.i17.3797.
  • Tso G, Kaldas K, Springer J, et al. West Nile meningoencephalitis presenting as isolated bulbar palsy with hypercapnic respiratory failure: case report and literature review. J Intensive Care Med. 2016;31(4):285–287. doi: 10.1177/0885066615589734.
  • Sciturro M, Rehl S, Klingensmith J. A rare case of neuroinvasive West Nile virus in Florida presenting as GuillainBarré syndrome. Cureus. 2022;14(12):e33138. doi: 10.7759/cureus.33138.
  • Scarciglia A, Roncucci L, Benatti P. A West Nile virus infection expressed as unilateral limb paralysis and complicated by Parsonage-Turner syndrome: a case report. J Med Case Rep. 2023;17(1):54. doi: 10.1186/s13256-023-03756-w.
  • Rosenheck MS, Higham C, Sanzone K, et al. New-onset bell’s palsy after neuroinvasive West Nile virus. BMJ Case Rep. 2022;15(7):e249770. doi: 10.1136/bcr-2022-249770.
  • Rousseau A, Haigh O, Ksiaa I, et al. Ocular manifestations of West Nile virus. Vaccines (Basel). 2020;8(4):641. doi: 10.3390/vaccines8040641.
  • Srichawla BS. Neuroinvasive West Nile virus (WNV) encephalitis with Anton syndrome: Epidemiology and pathophysiology review. Cureus. 2022;14(6):e26264. doi: 10.7759/cureus.26264.
  • Bakos I, Mahdi M, Kardos L, et al. Clinical spectrum and CSF findings in patients with West-Nile virus infection, a retrospective cohort review. Diagnostics (Basel). 2022;12(4):805. doi: 10.3390/diagnostics12040805.
  • Bailey C, Mach J, Kataria S, et al. West Nile virus encephalitis: a report of two cases and review of neuroradiological features. Radiol Case Rep. 2020;15(11):2422–2426. doi: 10.1016/j.radcr.2020.09.023.
  • Leis AA, Grill MF, Goodman BP, et al. Tumor necrosis Factor-Alpha signaling may contribute to chronic West Nile virus post-infectious proinflammatory state. Front Med (Lausanne). 2020;7:164. doi: 10.3389/fmed.2020.00164.
  • Hansen M, Nolan MS, Gorchakov R, et al. Unique cytokine response in West Nile virus patients who developed chronic kidney disease: a prospective cohort study. Viruses. 2021;13(2):311. doi: 10.3390/v13020311.
  • Kasule SN, Gupta S, Patron RL, et al. Neuroinvasive West Nile virus infection in solid organ transplant recipients. Transpl Infect Dis. 2023;25(1):e14004. doi: 10.1111/tid.14004.
  • Weatherhead JE, Miller VE, Garcia MN, et al. Long-term neurological outcomes in West Nile virus-infected patients: an observational study. Am J Trop Med Hyg. 2015;92(5):1006–1012. doi: 10.4269/ajtmh.14-0616.
  • Lino A, Erickson TA, Nolan MS, et al. A preliminary study of proinflammatory cytokines and depression following West Nile virus infection. Pathogens. 2022;11(6):650. doi: 10.3390/pathogens11060650.